Korkaya et al. previously reported that drug resistance in HER2 overexpressing cell lines with PTEN deletion by long term culture with trastuzumab (LTT) induces characteristics of the EMT and expands the breast cancer stem cell (BCSC) population19. The gene discussed is ERBB2; the disease is breast cancer.